The possible role of remnant-like particles as a risk factor for sudden cardiac death
暂无分享,去创建一个
K. Nakajima | T. Nakano | S. Takeichi | Y. Nakajima | M. Osawa | N. Yukawa | T. Saito | Y. Seto | T. Nakano | M. Adachi | K. Jitsukata | K. Horiuchi | T. Wang | K. Nakajima | M. Adachi | T. Wang | T. Saito | N. Yukawa | S. Takeichi | K. Horiuchi | Y. Nakajima | Y. Seto | K. Jitsukata | M. Osawa
[1] J. Enticknap. Lipids in cadaver sera after fatal heart attacks , 1961, Journal of clinical pathology.
[2] R. Havel,et al. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. , 1972, Journal of lipid research.
[3] S. Takeichi,et al. Fluidity of cadaveric blood after sudden death: Part II: Mechanism of release of plasminogen activator from blood vessels , 1985, The American journal of forensic medicine and pathology.
[4] K. Nakajima,et al. A New Assay Method for Remnant Lipoproteins and Its Clinical Significance: -1) The Quantification of Serum RLP-C (remnant-like particle cholesterol) in a Fasting State-@@@―I. 空腹時血清RLP-C (remnant like particles-cholesterol)の測定法とその診断的有用性について― , 1992 .
[5] T. Nikkari,et al. Stability of plasma total cholesterol, triglycerides, and apolipoproteins B and A-I during the early postmortem period. , 1988, Journal of forensic sciences.
[6] Kunio Ichikawa,et al. REMNANT-LIKE PARTICLES IN VARIOUS LIVER DISEASES , 1991 .
[7] A. Steinmetz. Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting. , 1987, Journal of Lipid Research.
[8] C. Sing,et al. Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.
[9] S. Takeichi,et al. Fluidity of cadaveric blood after sudden death: Part I Postmortem fibrinolysis and plasma catecholamine level , 1984, The American journal of forensic medicine and pathology.
[10] T. Orchard,et al. A Comparison of Blood Lipid and Lipoprotein Values in Young Adults Who Die Suddenly and Unexpectedly from Atherosclerotic Coronary Artery Disease With Other Noncardiac Deaths , 1995, The American journal of forensic medicine and pathology.
[11] T. Sato,et al. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4. , 1990, Atherosclerosis.
[12] K. Nakajima,et al. Remnant‐like Particles and Restenosis of Coronary Arteries after PTCA , 1994, Annals of the New York Academy of Sciences.
[13] J. Glanville. Post-mortem Serum Cholesterol Levels , 1960, British medical journal.
[14] D. Waters,et al. Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events , 1993, Circulation.
[15] J. Barboriak,et al. Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B. , 1984, Atherosclerosis.
[16] I. Tokunaga,et al. Fluidity of cadaveric blood after sudden death: Part III. Acid-base balance and fibrinolysis. , 1984, The American journal of forensic medicine and pathology.
[17] R. Havel,et al. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. , 1996, The Journal of clinical investigation.
[18] Y. Matsuzawa,et al. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. , 1984, Atherosclerosis.
[19] K. Nakajima,et al. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. , 1994, Journal of atherosclerosis and thrombosis.
[20] R. Mahley,et al. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. , 1982, Journal of lipid research.
[21] J. Davignon,et al. Triglycerides: a risk factor for coronary heart disease. , 1996, Atherosclerosis.
[22] M. Barbir,et al. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. , 1988, British heart journal.
[23] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[24] T. Lehtimäki. Determination of apolipoprotein E phenotypes from stored or postmortem serum samples. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[25] R. Havel,et al. Remnants of Lipoproteins of Intestinal and Hepatic Origin in Familial Dysbetalipoproteinemia , 1983, Arteriosclerosis.
[26] T. Saito,et al. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[27] K. Nakajima,et al. Postprandial remnant-like particles and coronary artery disease , 1994 .
[28] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[29] M. Okazaki,et al. High-performance liquid chromatography of serum lipoproteins. , 1986, Methods in enzymology.
[30] R. Havel,et al. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. , 1992, Journal of lipid research.
[31] R. Mahley,et al. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. , 1981, The Journal of clinical investigation.
[32] P. Hekali,et al. Serum lipids in angiographically assessed coronary atherosclerosis. , 1978, Chest.
[33] K. Nakajima,et al. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. , 1994, Journal of atherosclerosis and thrombosis.
[34] K. Nakajima,et al. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. , 1995, Thrombosis research.
[35] J. Strong,et al. Lipoproteins and apolipoproteins in postmortem serum. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[36] K. Nakajima,et al. High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis. , 1996, Nihon Jinzo Gakkai shi.
[37] K. Nakajima,et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[38] J. Fekete,et al. The Use of Routine Laboratory Tests in Postmortem Examinations , 1974 .
[39] I. Holme,et al. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. , 1992, Blood pressure. Supplement.
[40] H N NAUMANN,et al. Postmortem liver function tests. , 1956, American journal of clinical pathology.
[41] G. Assmann,et al. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study. , 1992, The American journal of cardiology.
[42] S. Shapiro,et al. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.